Medical
Pharmaceutical
Research And Development
Madrigal Pharmaceuticals
$103.119876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$103.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$3.50 (-3.28%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell MDGL and other stocks, options, ETFs, and crypto commission-free!
About
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Read More The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.
Employees
17
Headquarters
West Conshohocken, Pennsylvania
Founded
2011
Market Cap
1.59B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
278.67K
High Today
$107.45
Low Today
$101.75
Open Price
$105.32
Volume
51.28K
52 Week High
$325.98
52 Week Low
$91.56
Collections
Medical
Pharmaceutical
Research And Development
Health
Cancer Prevention
Technology
News
Yahoo FinanceMay 1
Is Madrigal Pharmaceuticals, Inc. (MDGL) A Good Stock To Buy?
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment that leads to companies swapping their equity for debt and focusing mostly on short-term performance such as beating the quarterly earnings estimates.
NasdaqApr 22
Madrigal Pharmaceuticals Enters Oversold Territory (MDGL)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30. In trading on Monday, shares of Madrigal Pharmaceuticals Inc (Symbol: MDGL) entered into oversold territory, hitting a...
Price Paid on Robinhood
26% Lower
Right Now
52 Week Low
$91.56
Average Price Paid
$139.78
52 Week High
$325.98
Earnings
-$0.98
-$0.98
-$0.97
-$0.97
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.97 per share
Actual
-$0.98 per share